The Effects of Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.
Phase of Trial: Phase IV
Latest Information Update: 12 Jun 2019
Price : $35 *
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 12 Jun 2019 Last checked against ClinicalTrials.gov: US National Institutes of Health
- 07 Jun 2019 Status changed from recruiting to completed.
- 18 Dec 2017 New trial record